Forgot your password?

Forgot your username?

database > company
Soft Tissue Regeneration, Inc.
Medical Devices & Tech
142 Temple Street, Suite 206
New Haven, CT 06510 USA
phone:973-879-6367
fax:
Symbol Private
Founded 2008
Employees 1
www.SoftTissueRegeneration.com
Research Sector Medical Devices & Tech
Summary Description
Soft tissue regeneration for sports medicine
Management
Joseph W. Reilly, President and CEO; Cato T. Laurencin, MD, PhD, Scientific Founder;
Keywords
sports medicine, ACL, Regenerative,

Comment | Printable Version | Modify profile |
Updated: Feb. 04, 2012

Description
Soft Tissue Regeneration Inc. (“STR”) is a medical device company that defines new technologies for the soft tissue regeneration segment of the sports medicine market. The Company has developed and tested the L-C Ligament®, a breakthrough biodegradable scaffold that in vivo studies have shown to regenerate the anterior cruciate ligament (ACL). Typical ACL repair consists of using autograft material, which entails unpredictable resorption characteristics and may cause damage to surrounding donor tissue, or allograft material, which is taken from cadavers and can transmit disease or infection. The L-C Ligament® is a breakthrough in facilitating the regeneration of native, natural ACL that is capable of carrying normal load after resorption of the scaffold. STR has obtained exclusive worldwide rights to a patent for the L-C Ligament®. This earlier-stage medical device company has also developed the STR GRAFT, a biodegradable scaffold to augment rotator cuff reconstruction, which has proved successful in several large animal studies and is currently undergoing 501(k) approval in the US.
Products / Services
L-C Ligament a biodegradable scaffold to regenerate the ACL. STR GRAFT a rotator cuff augmentation device.
Funding
Raised Series A of $4 million Seeking a Series B of $7 million with $2 million of convertible notes already raised from current investors.